Women With Heterozygous FH Less Likely to Receive Treatment Women With Heterozygous FH Less Likely to Receive Treatment

Women face a series of gender disparities in the diagnosis and management of heterozygous familial hypercholesterolemia that leave them less likely to achieve lipid goals, suggests registry data.Medscape Medical News

Source: Medscape Cardiology Headlines - October 19, 2020 Category: Cardiology Tags: Cardiology News Source Type: news